Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[From HIV infection to AIDS].

J C Gluckman, D Klatzmann

    Nouvelle Revue Francaise D'Hematologie
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Human immunodeficiency virus (HIV) causes AIDS by targeting CD4+ lymphocytes and macrophages. Viral properties and host factors influence disease diversity and immune abnormalities.

    Area of Science:

    • Virology
    • Immunology
    • Pathology

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis.

    Journal of neurology·2023
    Same author

    Serum tryptophan metabolites are associated with erosive hand osteoarthritis and pain: results from the DIGICOD cohort.

    Osteoarthritis and cartilage·2023
    Same author

    Specific Follicular Helper T Cell Signature in Takayasu Arteritis.

    Arthritis & rheumatology (Hoboken, N.J.)·2021
    Same author

    Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study.

    Diabetes & metabolism·2020
    Same author

    The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.

    Mucosal immunology·2016
    Same author

    Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity.

    Vaccine·2016